Abstract
Lung cancer is the major cause of cancer deaths worldwide due to its late diagnosis and poor outcome. Understanding genomic medicine may widen our vision into the oncogenesis of lung cancer and may open the door to improvements in the clinical management of lung cancer. It is well known that almost half of all genes are regulated by microRNAs (miRNAs). This review focuses on the role of miRNAs in lung cancer and also touches on the value of miRNA-based novel therapies for lung cancers.
| Original language | English |
|---|---|
| Pages (from-to) | 901-906 |
| Number of pages | 6 |
| Journal | OncoTargets and Therapy |
| Volume | 7 |
| DOIs | |
| State | Published - 4 Jun 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarker
- Chemotherapy
- Lung cancer
- MicroRNA
- Radiotherapy
Fingerprint
Dive into the research topics of 'The potential clinical applications and prospects of microRNAs in lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver